RTW Biotech Opportunities (LON:RTW) Shares Down 0.7% – What’s Next?

RTW Biotech Opportunities (LON:RTWGet Free Report) dropped 0.7% on Wednesday . The stock traded as low as GBX 1.47 ($0.02) and last traded at GBX 1.47 ($0.02). Approximately 98,745 shares changed hands during trading, a decline of 80% from the average daily volume of 504,050 shares. The stock had previously closed at GBX 1.48 ($0.02).

RTW Biotech Opportunities Trading Down 0.7 %

The stock has a market capitalization of £4.93 million, a PE ratio of 4.08 and a beta of 0.60. The stock has a 50 day moving average price of GBX 1.53 and a 200-day moving average price of GBX 1.52.

About RTW Biotech Opportunities

(Get Free Report)

RTW Biotech Opportunities Ltd is a venture capital fund. The fund specializes in directly investing and early-stage. The fund specializes in identifying transformative assets with high growth potential across the life sciences, biopharmaceutical and medical technology sectors. The fund invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.

See Also

Receive News & Ratings for RTW Biotech Opportunities Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTW Biotech Opportunities and related companies with MarketBeat.com's FREE daily email newsletter.